Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04120246
Brief Title: Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer

First Submitted : October 7, 2019
First Submitted that Met QC Criteria : October 7, 2019
First Posted : October 9, 2019

Last Update Submitted that Met QC Criteria : October 27, 2021
Last Update Posted : October 29, 2021